서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 8 of 8

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2010	개화기 출판의 목적 연구 : 생산 주체별 차이에 관하여 김민환 Journal of Communication Research, Vol.47 No.2. pp. 100-133	view file
2016-07	Application of montmorillonite in bentonite as a pharmaceutical excipient in drug delivery systems Park, Ju-Hwan; Shin, Hyeon-Jong; Kim, Min Hwan; Kim, Ji-Su; Kang, Naewon; Lee, Jae Young; Kim, Ki Taek; Lee, Jangik; Kim, Dae-Duk Journal of Pharmaceutical Investigation, Vol.46 No.4, pp.363-375	DOI
2016-11	Development of HPLC method for the determination of buspirone in rat plasma using fluorescence detection and its application to a pharmacokinetic study Kim, Ki Taek; Lee, Jae-Young; Park, Ju-Hwan; Kim, Min Hwan; Kim, Ji-Su; Shin, Hyeon-Jong; Kang, Naewon; Cho, Hyun-Jong; Yoon, In-Soo; Kim, Dae-Duk Chemical and Pharmaceutical Bulletin, Vol.64 No.11, pp.1582-1588	DOI
2022-09	Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer: The Neo-PATH Phase 2 Nonrandomized Clinical Trial Ahn, Hee Kyung; Sim, Sung Hoon; Suh, Koung Jin; Kim, Min Hwan; Jeong, Jae Ho; Kim, Ji-Yeon; Lee, Dae-Won; Ahn, Jin-Hee; Chae, Heejung; Lee, Kyung-Hun; Kim, Jee Hyun; Lee, Keun Seok; Sohn, Joo Hyuk; Choi, Yoon-La; Im, Seock-Ah; Jung, Kyung Hae; Park, Yeon Hee JAMA oncology, Vol.8 No.9, pp.1271-1277	DOI
2023-11	Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial Takahashi, Masato; Cortés, Javier; Dent, Rebecca; Pusztai, Lajos; McArthur, Heather; Kümmel, Sherko; Denkert, Carsten; Park, Yeon Hee; Im, Seock-Ah; Ahn, Jin-Hee; Mukai, Hirofumi; Huang, Chiun-Sheng; Chen, Shin-Cheh; Kim, Min Hwan; Jia, Liyi; Li, Xin Tong; Tryfonidis, Konstantinos; Karantza, Vassiliki; Iwata, Hiroji; Schmid, Peter Jama Network Open, Vol.6 No.11, p. e2342107	DOI
2023-12	Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16) Kim, Se Hyun; Im, Seock-Ah; Suh, Koung Jin; Lee, Kyung-Hun; Kim, Min Hwan; Sohn, Joohyuk; Park, Yeon Hee; Kim, Ji-Yeon; Jeong, Jae Ho; Lee, Kyoung Eun; Choi, In Sil; Park, Kyong Hwa; Kim, Hee-Jun; Cho, Eun Kyung; Park, So Yeon; Kim, Milim; Kim, Jee Hyun European Journal of Cancer, Vol.195, p. 113386	DOI
2024	Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study Drew, Yvette; Kim, Jae-Weon; Penson, Richard T.; O'Malley, David M.; Parkinson, Christine; Roxburgh, Patricia; Plummer, Ruth; Im, Seock-Ah; Imbimbo, Martina; Ferguson, Michelle; Rosengarten, Ora; Steeghs, Neeltje; Kim, Min Hwan; Gal-Yam, Einav; Tsoref, Daliah; Kim, Jae-Hoon; You, Benoit; De Jonge, Maja; Lalisang, Roy; Gort, Eelke; Bastian, Sara; Meyer, Kassondra; Feeney, Laura; Baker, Nigel; Ah-See, Mei-Lin; Domchek, Susan M.; Banerjee, Susana Clinical cancer research : an official journal of the American Association for Cancer Research, Vol.30 No.1, pp.50-62	DOI
2024	A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15) Baek, Sun Kyung; Jeong, Jae-ho; Jung, Kyunghae; Ahn, Hee Kyung; Kim, Min Hwan; Sohn, Joohyuk; Park, In Hae; Ahn, Jin Seok; Lee, Dae-Won; Im, Seock-Ah; Sim, Sung Hoon; Lee, Keun Seok; Hyun Kim, Jee; Shim, Hyun-Jeong; Chae, Yeesoo; Koh, Su-Jin; Lee, Hyorak; Lee, Jieun; Byun, Jae-Ho; Seol, Youngmi; Lee, Eun Mi; Jee, Hee-Jung; An, Hyonggin; Park, Eun Byeol; Suh, Young Ju; Lee, Kyoung Eun; Park, Yeon Hee Therapeutic Advances in Medical Oncology, Vol.16, pp.1-15	DOI

1